Trial Profile
A 28-day, Double-blind, Randomized, Reference-controlled Open Psoriasis Plaque Test for Within Subject Comparison of Efficacy and Safety of Mapracorat 0.1% Ointment and 4 Reference Products in Symptomatic Volunteers With Stable Plaque-type Psoriasis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jan 2018
Price :
$35
*
At a glance
- Drugs Mapracorat (Primary) ; Betamethasone-dipropionate/calcipotriol; Calcipotriol; Clobetasol; Prednicarbate
- Indications Plaque psoriasis
- Focus Pharmacokinetics
- Sponsors Bayer
- 22 Jan 2018 New trial record